White Kyle C, Bellomo Rinaldo, Laupland Kevin B, Gatton Michelle L, Ostermann Marlies, McIlroy Philipa, Luke Stephen, Garrett Peter, Tabah Alexis, Whebell Stephen, Marella Prashanti, McCullough James, Shekar Kiran, Attokaran Antony G, Kumar Aashish, Meyer Jason, Sanderson Barnaby, Serpa-Neto Ary
Intensive Care Unit, Princess Alexandra Hospital, Woolloongabba, QLD, Australia; Intensive Care Unit, Queen Elizabeth II Jubilee Hospital, Coopers Plains, QLD, Australia; School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia; Mayne Academy of Critical Care, Faculty of Medicine, University of Queensland, St Lucia, QLD, Australia.
Department of Intensive Care, Austin Hospital, Heidelberg, VIC, Australia; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.
J Crit Care. 2025 Jun;87:155016. doi: 10.1016/j.jcrc.2025.155016. Epub 2025 Jan 23.
In critically ill patients with acute kidney injury (AKI), a fluid balance (FB) > 2 L at 72 h after AKI diagnosis is associated with adverse outcomes. Identification of patients at high-risk for such fluid accumulation may help prevent it.
We used Australian electronic medical record (EMR)-based clinical data to develop the "AKI-FB risk score", validated it in a British cohort and used it to predict a positive FB >2 L at 72 h after AKI diagnosis.
We developed the AKI-FB score in 32,030 patients with a median age of 63 years and a median APACHE 2 score of 16. We validated it in 4465 patients, with significant differences in admission diagnoses and interventions. The key score variables were admission after trauma, sepsis or septic shock, and, on the day of AKI diagnosis, highest creatinine, daily cumulative FB, mechanical ventilation, noradrenaline use, noradrenaline equivalent dose >0.07 μg/kg/min, lactate ≥2 mmol/L, transfusion, and nutritional support. A score threshold of 32 had a sensitivity of 75 % and a specificity of 72 % for predicting a > 2 L positive FB with an AUC-ROC of 0.805; 95 % CI 0.799 to 0.810. External validation demonstrated an AUC of 0.761 (95 % CI 0.746 to 0.775).
We developed and validated the "AKI-FB risk score" to predict patients who developed a positive FB >2 L within 72 h of AKI diagnosis. This prediction score was robust and facilitated the identification of high-risk AKI patients who could be the tarted for preventive measures and be included in future clinical trials of FB management.
在急性肾损伤(AKI)的危重症患者中,AKI诊断后72小时液体平衡(FB)>2L与不良预后相关。识别有这种液体蓄积高风险的患者可能有助于预防。
我们使用基于澳大利亚电子病历(EMR)的临床数据开发了“AKI-FB风险评分”,在一个英国队列中对其进行验证,并使用它来预测AKI诊断后72小时FB>2L。
我们在32030例患者中开发了AKI-FB评分,这些患者的中位年龄为63岁,中位急性生理与慢性健康状况评分系统(APACHE)Ⅱ评分为16分。我们在4465例患者中对其进行验证,这些患者在入院诊断和干预方面存在显著差异。关键评分变量包括创伤、脓毒症或脓毒性休克后入院,以及在AKI诊断当天,最高肌酐水平、每日累积FB、机械通气、去甲肾上腺素使用、去甲肾上腺素等效剂量>0.07μg/kg/min、乳酸≥2mmol/L、输血和营养支持。评分阈值为32时,预测FB>2L阳性的敏感性为75%,特异性为72%,曲线下面积(AUC-ROC)为0.805;95%置信区间(CI)为从0.799至0.810。外部验证显示AUC为0.761(95%CI为0.746至0.775)。
我们开发并验证了“AKI-FB风险评分”,以预测在AKI诊断后72小时内出现FB>2L阳性的患者。该预测评分可靠,有助于识别高风险AKI患者,这些患者可作为预防措施的目标人群,并纳入未来FB管理的临床试验。